Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
about
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important differenceReproducibility of dynamically represented acoustic lung images from healthy individuals.Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosisMoving beyond Karnofsky and ECOG Performance Status Assessments with New TechnologiesExercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumoniaRespiratory disease and respiratory physiology: putting lung function into perspective interstitial lung diseaseThe peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosisPeriostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis in Saudi Arabia: Demographic, clinical, and survival data from two tertiary care hospitalsMRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosisImpact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.miR-210 promotes IPF fibroblast proliferation in response to hypoxia.Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test.The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE).Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseasesApplication of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPDPirfenidone treatment of idiopathic pulmonary fibrosis.Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.Utility of the 6-minute walk test following lung transplantation.Severity classification for idiopathic pulmonary fibrosis by using fuzzy logicExercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis.The Microbiome and the Respiratory TractInterstitial lung abnormalities and reduced exercise capacity.Cardiopulmonary exercise testing in lung transplantation: a review.Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosisDistance saturation product predicts health-related quality of life among sarcoidosis patients.The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.Heart rate response to a timed walk and cardiovascular outcomes in older adults: the cardiovascular health study.Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.
P2860
Q24628952-46E1DFD0-FC33-4CC7-B3FF-8AC8BF315223Q24649002-6659B28C-0761-4E0D-9619-1462DB60BDDFQ26747694-1748A2D4-2A86-4099-B329-BC18603F0C85Q26749492-239A8F27-A7B4-445E-AE0E-CB88F565E1FFQ26785390-F73459D1-1F4D-4949-B706-4452A2BA114EQ27001599-172BD26E-D078-4755-B2DD-B7FE6C5E8911Q28728072-437E3360-F58F-437D-BF5E-F996EE09AD15Q30415751-B2ADE846-18AA-45EB-9EE8-4B5F1F69AFD1Q30834669-7D7D960C-95C3-4B98-9AF1-F91ED71F2BC6Q30983821-80B41037-C260-4702-BF92-9FDE37940A6BQ33612767-12A19EA0-5FFB-4B99-8A40-29316071861DQ33652974-C5FA63A7-A5FB-4D89-8DED-4D21D276E6A4Q33783426-A6E643B8-5CA7-4C34-B436-61139A6766B0Q33788227-A099D799-3E23-42D3-B60B-C71ADE0CF20CQ33855641-3E2368B3-1B35-430B-A288-5706A7117A54Q33905090-16D9F6A6-AC96-412C-889D-D13ACD980D83Q34005618-B24E4D4F-DFAB-4A62-8A16-9216BF62471EQ34026607-539AE663-A6C7-48DA-A714-F8047C92E72CQ34062979-293296E7-9845-4D5C-974A-817060547B12Q34071333-ED89603A-F265-4032-A078-6A0DDC7CB994Q34156210-B01700D6-D3BB-4EAE-9993-076931B9FF5AQ34197933-13481D6F-BE2F-4B36-9B2C-DB5EBAC75E69Q34471290-5BD46757-E4C9-49E8-96C3-AFB8F1BA0197Q34574174-33E9E35E-A882-4FF5-BCCD-279B7337644EQ34776159-976C39BA-784D-438B-A3A9-CD3378AF01F0Q34986258-D5CDABB5-7679-415C-A7DF-4FF980CB4993Q35087202-B838CBA9-E05C-46EB-8F00-9B1141CFA157Q35112333-25ECF748-DCCD-439B-82F0-9F0142099074Q35606977-2BF49594-898B-43D2-A340-44077F1BD52DQ35610196-DDBB23C6-D7AF-43AA-975A-14F70BC35535Q35829947-F2CD2C6C-4FAD-4CEA-95E1-B230D779A0D5Q35889148-3FA218B7-B961-4309-A3E2-AD97EA127EB1Q35991326-632ACBC9-E496-4A20-9DDF-2D192120EA52Q36013692-5AE4BB9A-6FCC-491D-ABD0-39B98887665CQ36130247-94A738A4-C256-4D38-B809-F12BC42F8424Q36231734-38D9B156-54D4-4E5D-B473-4EC9EC206F54Q36451082-B69F47AF-4B1D-47E0-B240-C86A44046C26Q36719113-4AC98361-3386-4C7C-BDD8-E3BBDBAD2512Q36726418-383B8726-8A0C-4AA4-B75D-91EB10ADD5FDQ36734220-605AAA6C-6746-4157-8F0F-63FA24F455FB
P2860
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.
@en
Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.
@nl
type
label
Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.
@en
Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.
@nl
prefLabel
Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.
@en
Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.
@nl
P2093
P2860
P1476
Idiopathic pulmonary fibrosis: ...... ology and six-minute-walk test
@en
P2093
Barry H Gross
Chris Fraley
Ella A Kazerooni
Fernando J Martinez
Galen B Toews
Kevin R Flaherty
Thomas V Colby
Vibha Lama
William D Travis
P2860
P304
P356
10.1164/RCCM.200604-488OC
P407
P577
2006-07-06T00:00:00Z